drugset / Trial / NCT03058835

IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project

NCT03058835

Phase 4 Unknown 125 enrolled Rutgers, The State University of New Jersey
NaSingle-groupOpen-labelPrevention

Summary

The overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP procurement through the established access procedures, and adherence to Truvada PrEP among US women at risk for HIV acquisition.

Timeline

Start
2016-09
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenofovir disoproxil fumarate Small molecule
Subject emtricitabine Other / unclassified

Indications

No indication recorded.